GHK-Cu and copper peptides in dermal research

A tripeptide with a metal centre

GHK is a three-residue peptide — glycyl-L-histidyl-L-lysine — that occurs naturally in plasma and whose concentration declines with age. Its research interest derives almost entirely from its high affinity for copper(II), which it coordinates to form the GHK-Cu complex.

The complex, not the free peptide, is the active species in most published work. This distinction matters commercially: GHK and GHK-Cu are separate products with different molecular weights, different appearance — GHK-Cu is a distinctive blue — and different reported activity profiles.

Reported activity in dermal models

The published literature describes effects on extracellular matrix turnover: stimulation of collagen and glycosaminoglycan synthesis in fibroblast culture, modulation of matrix metalloproteinase and TIMP expression, and antioxidant behaviour attributed in part to the copper centre's role in superoxide dismutase-like activity.

A separate strand of work reports gene-expression modulation across a broad transcript set in cultured fibroblasts, and effects on wound-margin behaviour in animal models. As with most of this class, the evidence base is preclinical and in vitro.

Handling copper chemistry

GHK-Cu imposes constraints that peptide-only compounds do not. It is light-sensitive and should be handled in amber vessels or protected from ambient light. It is incompatible with strong reducing agents, including ascorbic acid, which reduces copper(II) and dissociates the complex — a common and easily missed source of failed experiments in combined-formulation work.

It also chelates. In buffers containing EDTA or other chelating agents the copper is competitively stripped, leaving free peptide and free chelate rather than the intended complex. Check buffer composition before assuming a null result reflects biology.

Solutions are blue; loss of colour indicates the complex has dissociated and the material should not be used for work that depends on the coordinated form.

The copper complex is the compound

GHK is a tripeptide — glycyl-L-histidyl-L-lysine — but the material of research interest is the copper(II) complex, in which the peptide chelates a single copper ion through the histidine imidazole, the N-terminal amine and the peptide nitrogen. The complex, not the free peptide, is what the literature characterises, and the two behave differently in essentially every assay.

This has direct handling consequences. Copper coordination is pH-dependent, so a diluent far from neutral can shift the equilibrium and partially dissociate the complex. Chelating agents in a buffer — EDTA is the obvious offender — will strip the copper outright, converting the compound into the free peptide without any visible change beyond colour.

The characteristic blue colour of the complex is itself a crude readout: intensity tracks with copper coordination, and a preparation that is colourless has lost it. Any buffer choice for GHK-Cu work should be checked for chelators before the experiment rather than after an unexpected null result.

Analytical characterisation of a metal complex

Standard reversed-phase purity analysis characterises the peptide component. Copper content is a separate determination, typically by an atomic or inductively coupled plasma method, and a thorough certificate reports both — because a preparation can be a chromatographically pure peptide with substoichiometric copper.

Mass spectrometry on the complex is complicated by copper's isotope pattern, which produces a distinctive doublet rather than a single expected mass. That pattern is a useful confirmation of coordination in its own right, and its absence in a spectrum reported for a copper peptide is worth questioning.

For storage, the complex is stable as a lyophilized solid under standard conditions but is more sensitive in solution than the free peptide, particularly with light exposure. Amber vials or foil wrapping and single-use aliquots are the usual precautions.